Search

Your search keyword '"Elzinga, Paul A."' showing total 10 results

Search Constraints

Start Over You searched for: Author "Elzinga, Paul A." Remove constraint Author: "Elzinga, Paul A." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
10 results on '"Elzinga, Paul A."'

Search Results

1. The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancer

2. Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2

3. Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis

4. Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton’s Tyrosine Kinase (BTK)

5. Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors

6. Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2.

8. Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer

9. Abstract 5417: The identification of BMS-595, an orally active imidazo[1,2-b]pyridazine CK2 inhibitor with in vivo anti-tumor activity

10. Abstract 5395: Anti-tumor activity of BMS-595, a novel CK2 kinase inhibitor

Catalog

Books, media, physical & digital resources